JINS HOLDINGS Inc. (FRA:5F3)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	1,086	753	508	713	1,291	1,350
Market Cap Growth	140.26%	48.09%	-28.71%	-44.77%	-4.40%	12.09%
Enterprise Value	1,060	741	527	716	1,291	1,365
Last Close Price	45.60	31.57	20.77	29.45	53.15	55.70
PE Ratio	22.84	25.98	45.57	132.73	50.91	101.28
PS Ratio	1.90	1.46	1.10	1.49	2.62	2.84
PB Ratio	6.04	4.74	3.69	4.88	8.29	9.62
P/TBV Ratio	7.00	5.26	4.06	5.47	9.32	11.01
P/FCF Ratio	-	13.33	25.59	57.54	48.30	31.17
P/OCF Ratio	-	11.05	13.26	22.67	33.13	22.05
EV/Sales Ratio	1.94	1.44	1.14	1.50	2.62	2.87
EV/EBITDA Ratio	12.41	11.10	10.72	15.96	21.64	20.50
EV/EBIT Ratio	15.53	15.24	17.18	30.16	33.19	30.88
EV/FCF Ratio	-	13.12	26.54	57.81	48.31	31.50
Debt / Equity Ratio	0.18	0.48	0.57	1.12	1.16	1.38
Debt / EBITDA Ratio	-	1.15	1.61	3.64	3.01	2.91
Debt / FCF Ratio	-	1.36	3.99	13.19	6.73	4.47
Asset Turnover	-	1.68	1.47	1.24	1.20	1.34
Inventory Turnover	-	3.83	3.26	2.75	2.85	2.70
Quick Ratio	0.85	0.98	1.53	1.14	2.57	2.27
Current Ratio	1.33	1.26	2.11	1.46	3.16	2.73
Return on Equity (ROE)	-	19.72%	8.35%	3.69%	17.33%	8.41%
Return on Assets (ROA)	-	9.90%	6.08%	3.85%	5.93%	7.77%
Return on Capital (ROIC)	-	13.56%	7.82%	4.78%	7.35%	10.07%
Return on Capital Employed (ROCE)	35.10%	27.60%	14.40%	10.40%	11.90%	13.80%
Earnings Yield	4.38%	3.85%	2.20%	0.75%	1.96%	0.99%
FCF Yield	-	7.50%	3.91%	1.74%	2.07%	3.21%
Dividend Yield	1.27%	1.20%	1.16%	0.41%	0.65%	0.36%
Payout Ratio	-	22.59%	17.20%	115.07%	35.42%	70.95%
Buyback Yield / Dilution	4.44%	2.10%	2.14%	-0.24%	-3.22%	-2.77%
Total Shareholder Return	5.71%	3.30%	3.30%	0.17%	-2.57%	-2.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.